Samia Boussouar

Samia Boussouar

Auto-generated profile, based on publicly available information

Samia Boussouar

Department of Cardiothoracic Imaging, Pitié-Salpêtrière University Hospital AP-HP, Sorbonne University, Paris, France

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2023 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
JSJoe-Elie Salem
Joe-Elie Salem
MBMarie Bretagne
Marie Bretagne
BABaptiste Abbar
Baptiste Abbar
SLSarah Leonard-Louis
Sarah Leonard-Louis
SEStéphane Ederhy
Stéphane Ederhy
YAYves Allenbach
Yves Allenbach
Immune-checkpoint-inhibitor (ICI)–associated myotoxicity involves the heart (myocarditis) and skeletal muscles (myositis), which frequently occur concurrently and are highly fatal. We report the results of a strategy that included identification of individuals with severe ICI myocarditis by also screening for and managing concomitant respiratory muscle involvement with mechanical ventilation, as well as treatment with the CTLA4 fusion protein abatacept and the JAK inhibitor ruxolitinib. Forty cases with definite ICI myocarditis were included with pathologic confirmation of concomitant myositis in the majority of patients. In the first 10 patients, using recommended guidelines, myotoxicity-related fatality occurred in 60%, consistent with historical controls. In the subsequent 30 cases, we instituted systematic screening for respiratory muscle involvement coupled with active ventilation and treatment using ruxolitinib and abatacept. The abatacept dose was adjusted using CD86 receptor occupancy on circulating monocytes. The myotoxicity-related fatality rate was 3.4% (1/30) in these 30 patients versus 60% in the first quartile (P < 0.0001). These clinical results are hypothesis-generating and need further evaluation. Significance: Early management of respiratory muscle failure using mechanical ventilation and high-dose abatacept with CD86 receptor occupancy monitoring combined with ruxolitinib may be promising to mitigate high fatality rates in severe ICI myocarditis. See related commentary by Dougan, p. 1040. This article is highlighted in the In This Issue feature, p. 1027

1 October 2021 in Radiology
Verified
Journal Article
Closed access
MRMarie Pierre Revel
Marie Pierre Revel
SBSamia Boussouar
Samia Boussouar
CMConstance de Margerie-Mellon
Constance de Margerie-Mellon
ISInès Saab
Inès Saab
TLThibaut Lapotre
Thibaut Lapotre
HAHendy Abdoul
Hendy Abdoul
Using reverse transcription–polymerase chain reaction as the reference standard in 10 735 patients with suspected COVID-19 pneumonia, CT was 80% accurate and was also predictive of death or need fo... Background There are conflicting data regarding the diagnostic performance of chest CT for COVID-19 pneumonia. Disease extent at CT has been reported to influence prognosis. Purpose To create a lar...

25 November 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Nicolas DupinNicolas Dupin
Nicolas Dupin
AJAude Jary
Aude Jary
SBSamia Boussouar
Samia Boussouar
CSCharlotte Syrykh
Charlotte Syrykh
AGAmir Gandjbakhche
Amir Gandjbakhche
RPRomain Palich
Romain Palich
Kaposi’s sarcoma (KS) is a rare, atypical malignancy associated with immunosuppression and can be qualified as an opportunistic tumor, which responds to immune modulation or restoration. Four different epidemiological forms have been individualized (AIDS-related, iatrogenic, endemic or classic KS). Although clinical examination is sufficient to diagnose cutaneous lesions of KS, additional explorations are necessary in order to detect lesions involving other organs. New histological markers have been developed in recent years concerning the detection of HHV-8 latent or lytic proteins in the lesions, helping to confirm the diagnosis when it is clinically doubtful. More recently, the evaluation of the local immune response has also been shown to provide some guidance in choosing the appropriate therapeutic option when necessary. We also review the indication and the results of conventional radiological imaging and of non-invasive imaging tools such as 18F-fluoro-deoxy-glucose positron emission tomography, thermography and laser Doppler imaging for the diagnosis of KS and for the follow-up of therapeutic response in patients requiring systemic treatment.

2 March 2021 in European Radiology
Verified
Journal Article
Closed access
PDF file
SBSamia Boussouar
Samia Boussouar
ABAmira Benattia
Amira Benattia
JEJean.-Baptiste Escudié
Jean.-Baptiste Escudié
LGLaure Gibault
Laure Gibault
FCFrédérique Capron
Frédérique Capron
OSOlivier Sanchez
Olivier Sanchez

14 August 2019 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
RLRaphael Lhote
Raphael Lhote
Philippe A. GrenierPhilippe A. Grenier
Philippe A. Grenier
JHJulien Haroche
Julien Haroche
MMMakoto Miyara
Makoto Miyara
SBSamia Boussouar
Samia Boussouar
FAFleur Cohen Aubart
Fleur Cohen Aubart
Objectives: Interstitial lung disease (ILD) is a common feature of mixed connective tissue disease. However, many patients do not meet the criteria for mixed connective tissue disease and thus may be diagnosed as interstitial pneumonia with autoimmune features. The aim of this study was to characterize ILD associated with anti-ribonucleoprotein (RNP) antibodies. Methods: Chest computed tomography scans of patients with anti-RNP antibody who were seen between January 2011 and October 2015 were reviewed. The underlying disease was classified with international criteria using clinical and serological features. Results: Among 544 patients with anti-RNP antibodies, 188 had a chest computed tomography scan, and 48 (26%) of them had radiological features of ILD. The presence of ILD was significantly associated with dyspnea, crackles, arthritis, Raynaud phenomenon, myositis, and sicca syndrome. The most frequent pattern was nonspecific interstitial pneumonia in 39 patients (81%). Among patients with ILD, 17 (35%) had a radiological pattern consisting of cysts and ground-glass attenuation not fulfilling the lymphoid interstitial pneumonia criteria. In 3 patients, cysts were related to fibrosis; in 14 patients, cysts corresponded to an original ILD pattern. Conclusions: Interstitial lung disease was found in 26% of patients with anti-RNP antibodies independently of the underlying disease. Anti-RNP–associated ILD mainly corresponds to nonspecific interstitial pneumonia or an original pattern consisting of cysts and ground-glass attenuation.

1 November 2024 in Critical Care Medicine
Verified
Journal Article
Open access
NDNima Djavidi
Nima Djavidi
SBSamia Boussouar
Samia Boussouar
BDBaptiste Duceau
Baptiste Duceau
PBPetra Bahroum
Petra Bahroum
SRSimon Rivoal
Simon Rivoal
ABAdrien Bouglé
Adrien Bouglé
OBJECTIVES: Vascular complications after venoarterial extracorporeal membrane oxygenation (ECMO) remains poorly studied, although they may highly impact patient management after ECMO removal. Our aim was to assess their frequency, predictors, and management. DESIGN: Retrospective, observational cohort study. SETTING: Two ICUs from a tertiary referral academic hospital. PATIENTS: Adult patients who were successfully weaned from venoarterial ECMO between January 2021 and January 2022. INTERVENTIONS: None. PRIMARY OUTCOME: Vascular complications frequency related to ECMO cannula. MEASUREMENTS AND MAIN RESULTS: A total of 288 patients were implanted with venoarterial ECMO during the inclusion period. One hundred ninety-four patients were successfully weaned, and 109 underwent a CT examination to assess for vascular complications until 4 days after the weaning procedure. The median age of the cohort was 58 years (interquartile range [IQR], 46–64 yr), with a median duration of ECMO support of 7 days (IQR, 5–12 d). Vascular complications were observed in 88 patients (81%). The most frequent complication was thrombosis, either cannula-associated deep vein thrombosis (CaDVT) (n = 63, 58%) or arterial thrombosis (n = 36, 33%). Nonthrombotic arterial complications were observed in 48 patients (44%), with 35 (31%) presenting with bleeding. The most common site of CaDVT was the inferior vena cava, occurring in 33 (50%) of cases, with 20% of patients presenting with pulmonary embolism. There was no association between thrombotic complications and ECMO duration, anticoagulation level, or ECMO rotation flow. CT scans influenced management in 83% of patients. In-hospital mortality was 17% regardless of vascular complications. CONCLUSIONS: Vascular complications related to venoarterial ECMO cannula are common after ECMO implantation. CT allows early detection of complications after weaning and impacts patient management. Patients should be routinely screened for vascular complications by CT after decannulation.